EcoR1 Capital’s Aardvark Therapeutics AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.79M Buy
720,028
+323,834
+82% +$1.98M 0.17% 30
2026
Q2
$2.28M Buy
+396,194
New +$1.85M 0.11% 29

Other funds holding AARD

EcoR1 Capital's AARD Position: Q3 2026 in Review

EcoR1 Capital increased its Aardvark Therapeutics (AARD) stake by 82% in Q3 2026, buying an estimated $1.98M and bringing the position to 720,028 shares worth $3.79M. The position accounts for 0.17% of the portfolio, ranked #30.

EcoR1 Capital first reported a position in AARD in Q2 2026 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

  • EcoR1 Capital held 720,028 shares of Aardvark Therapeutics worth $3.79M as of Q3 2026.
  • EcoR1 Capital bought 323,834 Aardvark Therapeutics shares in Q3 2026, an estimated $1.98M.
  • Aardvark Therapeutics made up 0.17% of EcoR1 Capital's portfolio in Q3 2026, its #30 holding.
  • EcoR1 Capital first reported a position in Aardvark Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.